THYROID CARCINOMA
Clinical trials for THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Thyroid cancer drug under Long-Term safety watch
Disease control OngoingThis study looks at the safety and effectiveness of the drug sorafenib (Nexavar) in people with a type of advanced thyroid cancer that cannot be removed by surgery. Over 450 participants are being followed for up to 2 years to track side effects, how long they stay on the drug, a…
Matched conditions: THYROID CARCINOMA
Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 10:43 UTC
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: THYROID CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 10:33 UTC